| Code | Description | Claims | Beneficiaries | Total Paid |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,587 |
3,278 |
$109K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,555 |
1,099 |
$79K |
| 84443 |
Thyroid stimulating hormone (TSH) |
5,674 |
5,105 |
$75K |
| 81514 |
|
483 |
415 |
$70K |
| 80053 |
Comprehensive metabolic panel |
5,812 |
5,167 |
$53K |
| 80061 |
Lipid panel |
4,521 |
4,080 |
$50K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,083 |
1,003 |
$49K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,990 |
4,217 |
$38K |
| 87631 |
|
353 |
335 |
$36K |
| 85027 |
|
5,909 |
5,240 |
$34K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
938 |
886 |
$30K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,227 |
2,891 |
$27K |
| 87660 |
|
1,132 |
978 |
$20K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,025 |
2,639 |
$19K |
| 87480 |
|
1,132 |
978 |
$19K |
| 87510 |
|
1,131 |
978 |
$17K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
189 |
173 |
$15K |
| 84439 |
|
1,068 |
939 |
$8K |
| 86140 |
|
1,425 |
1,222 |
$6K |
| 84703 |
|
746 |
655 |
$5K |
| 81001 |
|
1,734 |
1,544 |
$5K |
| 0240U |
|
157 |
147 |
$5K |
| 83735 |
|
723 |
614 |
$4K |
| 82043 |
|
567 |
521 |
$3K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
49 |
44 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
54 |
52 |
$2K |
| 85610 |
|
407 |
230 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
54 |
52 |
$1K |
| 81003 |
|
690 |
624 |
$1K |
| 85018 |
|
571 |
523 |
$1K |
| 80050 |
General health panel |
37 |
25 |
$1K |
| 80076 |
|
124 |
116 |
$907.92 |
| 82565 |
|
101 |
80 |
$459.70 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
38 |
17 |
$442.62 |
| 85652 |
|
190 |
161 |
$431.52 |
| 84702 |
|
28 |
24 |
$303.10 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
16 |
14 |
$275.00 |
| 83690 |
|
25 |
25 |
$167.73 |
| 82570 |
|
35 |
28 |
$156.00 |
| 84460 |
|
28 |
25 |
$119.21 |
| 81015 |
|
44 |
41 |
$113.39 |
| 0352U |
|
227 |
206 |
$0.00 |